Tivdak 40 MG vials
Ended Awarded
- Contract number
- SPE2DB26FYM39
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,687
Award facts
- Contract value 100% obligated
- $9,687.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,687.08 to DMS Pharmaceutical Group Inc. for TIVDAK 40 mg vials on October 27, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was issued without a set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the awardee based on its established capability to supply pharmaceutical products to Department of Defense medical facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for military healthcare operations. The underlying IDC, designated as contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three optional 30-month renewal periods. Under this framework, DMS Pharmaceutical Group serves as a critical regional prime vendor contractor authorized to fulfill diverse pharmaceutical and medical supply requirements for Department of Defense healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FYM39?
SPE2DB26FYM39 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FYM39 worth?
The government has obligated $9,687 on SPE2DB26FYM39.
Is contract SPE2DB26FYM39 an order under another contract?
Yes. SPE2DB26FYM39 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM39 competed?
The extent of competition for SPE2DB26FYM39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award